Treatment Set TS333519 (Antigen Laboratories, Inc.)


Welcome to the PulseAid listing for the Treatment Set TS333519 drug offered from Antigen Laboratories, Inc.. This Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Antigen Laboratories, Inc.
NON-PROPRIETARY NAME: Treatment Set TS333519
SUBSTANCE NAME: ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; LOLIUM PERENNE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; DACTYLIS GLOMERATA POLLEN; AMBROSIA ARTEMI
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1986-10-31
END MARKETING DATE: 0000-00-00


Treatment Set TS333519 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTreatment Set TS333519 from Antigen Laboratories, Inc.
LABELER NAME: Antigen Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4000; 2000; 4000; 4000; .01; 2000; 4000; 4000([BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; [AU]/mL; [BAU]/mL; [AU]/mL)
START MARKETING DATE: 1986-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49288-0680_89f9e682-acd9-4cc7-982d-c32f69b33b07
PRODUCT NDC: 49288-0680
APPLICATION NUMBER: BLA102223

Other ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; LOLIUM PERENNE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; DACTYLIS GLOMERATA POLLEN; AMBROSIA ARTEMI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Antigen Laboratories, Inc.Treatment Set TS333519